BioCentury | Jan 14, 2020
Company News

Amid need for new pain options, FDA panel rebuffs Nektar’s ‘safer’ opioid

...scheduled for three other pain therapies this week: a fixed dose combination of tramadol and celecoxib...
BioCentury | Apr 19, 2019
Clinical News

Pfizer, Lilly to mull anti-NGF mAb's future after joint safety events spike in long-term readout

...subcutaneous injections of 2.5 or 5 mg tanezumab every eight weeks, or oral NSAIDs naproxen, celecoxib...
BioCentury | Oct 26, 2018
Clinical News

Detailed data for Pfizer, Lilly anti-NGF mAb highlighted at ACR/ARHP

...are expected in 1H19 from the Phase III A4091058 trial evaluating tanezumab compared with naproxen, celecoxib...
BioCentury | Oct 24, 2018
Clinical News

Detailed data for Pfizer, Lilly anti-NGF mAb highlighted at ACR/ARHP

...are expected in 1H19 from the Phase III A4091058 trial evaluating tanezumab compared with naproxen, celecoxib...
BioCentury | Oct 13, 2018
Product Development

Bourla’s breadcrumbs to value

...wake of patent losses for two of its major products -- Lipitor atorvastatin and Celebrex celecoxib...
BioCentury | Oct 1, 2018
Company News

Pfizer COO Bourla to succeed Read as CEO

...Pfizer through the patent cliff for two of its top-selling drugs, Lipitor atorvastatin and Celebrex celecoxib...
BioCentury | Jun 29, 2018
Clinical News

FDA approves CV label update for Pfizer's Celebrex

...FDA approved a label supplement for Celebrex celecoxib from Pfizer Inc. (NYSE:PFE) to include data from...
...include data from a postmarketing cardiovascular outcomes trial showing that the lowest approved dose of Celebrex...
...NYSE:PFE), New York, N.Y. Product: Celebrex celecoxib Business: Autoimmune, Inflammation, Neurology Chris Lieu Celebrex, Celecox, celecoxib (YM177, onsenal) Pfizer...
BioCentury | May 9, 2018
Distillery Therapeutics

Musculoskeletal

...treat Duchenne muscular dystrophy (DMD). In a mouse model of DMD, the COX-2 inhibitor Celebrex celecoxib...
...include investigating the mechanisms downstream of COX-2 inhibition. Pfizer Inc. and Astellas Pharma Inc. market Celebrex...
...CONTACT: Bernard J. Jasmin, University of Ottawa, Ottawa, Ontario email: jasmin@uottawa.ca Claire Quang Celebrex, Celecox, celecoxib (YM177, onsenal) University...
BioCentury | Apr 27, 2018
Clinical News

FDA panel affirms safety of Pfizer's Celebrex

...Advisory Committee voted 15-5 that the Phase IV CV outcomes PRECISION trial showed that Celebrex celecoxib...
...celecoxib from Pfizer Inc. (NYSE:PFE) had comparable cardiovascular safety to non-selective NSAIDS naproxen and ibuprofen. Celebrex...
...rheumatoid arthritis. Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Neurology Elizabeth S. Eaton Celebrex, Celecox, celecoxib (YM177, onsenal) Pfizer...
BioCentury | Apr 25, 2018
Company News

FDA panel affirms safety of Pfizer's Celebrex

...Advisory Committee voted 15-5 that the Phase IV CV outcomes PRECISION trial showed that Celebrex celecoxib...
...celecoxib from Pfizer Inc. (NYSE:PFE) had comparable cardiovascular safety to non-selective NSAIDS naproxen and ibuprofen. Celebrex...
...patients with chronic pain from osteoarthritis (OA) or rheumatoid arthritis. Elizabeth S. Eaton Celebrex, Celecox, celecoxib (YM177, onsenal) Pfizer...
Items per page:
1 - 10 of 278